Psychedelic Odyssey Conference: Exploring Consciousness with Integrative Medicine


July 20-21, 2024

Join us at the Psychedelic Odyssey Conference, a kaleidoscopic journey into integrative medicine's transformative realms. Immerse yourself in cutting-edge discussions on psychedelics like ketamine, kratom, mushrooms, and MDMA, uncovering their potential in mental health. Explore the intricacies of epigenetics and endocannabinoids, unraveling the tapestry of personalized healing. Delve into the sacred traditions of ayahuasca, connecting ancient wisdom with modern insights. Navigate the frontiers of addiction medicine, discovering innovative approaches to recovery. Join this vibrant convergence of experts, where diverse perspectives harmonize to illuminate the multifaceted landscape of integrative medicine and its profound impact on mind, body, and spirit.

Confirmed Speakers:

  • Erica Zelfand, ND
  • Oliver Grundman, PhD
  • Candace Lewis, PhD
  • Georgiana Cullen-Kerney, ND, MAc
  • Leanna Standish, NMD
  • Lindsay Wilkinson, ND, LAc
  • Alicia Bigelow, ND
  • Austin Perlmutter, MD

Moderated by Heather Zwickey, PhD

CE Credits:


12 PDA points to be applied for via NCCAOM (National Certification Commission for Acupuncture and Oriental Medicine)

NUNM is accredited by the North American Naturopathic Continuing Education Council (NANCEAC). This activity has been approved for a Total of 12.0 CEUs.

Webinar Details:

  • This fully online virtual event will be hosted through Zoom
  • Recordings of all conference presentations are provided for attendees at no additional cost
  • Recordings can be viewed for credit after the event if you do not attend live

Early Bird Deadlines:

  • 6/7/2024: all prices listed below increase by $50
  • 7/5/2024: all prices listed below increase by an additional $25


9:00 - 10:30 AM "Psychedelic Ketamine Experiences in the Clinical Setting: Case Studies and Discussion" Lindsay Wilkinson, ND, Lac
10:30 - 11:00 AM BREAK
11:00 - 12:30 PM "What is the Mi(gh)ter Hype of Kratom? Pharmacology, Potential Benefits and Harms of Mitragyna speciosa" Oliver Grundman, PhD
12:30 - 1:30 PM LUNCH
1:30 - 3:00 PM "Magic Mushrooms: Including the Efficacy & Safety of Oregon Psilocybin Services" Georgina Cullen-Kerney, ND, MAc
3:00 - 3:30 PM BREAK
3:30 - 5:00 PM "Bringing Ayahuasca to North America: Technical and Ethical Challenges" Leanna Standish, NMD


9:00 - 10:30 AM "Microdosing Psilocybin & LSD: What We Know So Far" Erica Zelfand, ND
10:30 - 11:00 AM BREAK
11:00 - 12:30 PM "38 Million Moments Shaping Your Epigenome: Exploring Psychedelic Healing" Candace Lewis, PhD
12:30 - 1:30 PM LUNCH
1:30 - 3:00 PM "Psychedelics: Effectors of Neuroinflammatory Programming" Austin Perlmutter, MD
3:00 - 3:30 PM BREAK
3:30 - 5:00 PM "Clinical Ketamine Use: Considerations in Special Populations" Alicia Bigelow, ND

Lindsay Wilkinson Headshot

Lindsay Wilkinson, ND, LAc

"Psychedelic Ketamine Experiences in the Clinical Setting: Case Studies and Discussion"

At the upcoming symposium on psychedelic medicine, I am thrilled to deliver a presentation centered on the transformative power of patient experiences and compelling case studies. Through an engaging narrative, I will illuminate the profound impact of psychedelic therapies on mental health treatment, drawing from real-world scenarios and clinical insights. By sharing diverse patient journeys and outcomes, I aim to showcase the therapeutic potential of psychedelic medicine in addressing a spectrum of mental health challenges. Attendees can expect to gain invaluable insights into the nuanced complexities of patient care, as well as the evolving landscape of psychedelic-assisted therapies. Together, we will explore the profound intersection of science, compassion, and hope, paving the way for a deeper understanding and appreciation of this groundbreaking field.

Bio: Dr. Lindsay Wilkinson is a highly trained and experienced healthcare professional specializing in mental health, gynecology, and digestive health. With a dedicated focus on non-ordinary states of consciousness, Dr. Wilkinson has undergone extensive clinical training to provide exceptional care in therapeutic ketamine treatment. She employs evidence-informed practices, utilizing a blend of traditional and modern diagnostic techniques to offer comprehensive patient care.

Having completed a rigorous CNME-approved residency at Kwan Yin Healing Arts Center in 2016, Dr. Wilkinson has since been at the forefront of delivering integrated healthcare services. Her approach emphasizes a holistic perspective, where she combines somatic techniques, bodywork, and acupuncture to foster body awareness, relieve pain, and optimize the mind-body connection.

Dr. Wilkinson's commitment to holistic healing extends to her incorporation of various bodywork modalities into her practice. These include Classical 5 Element Acupuncture, Tami Kent's Holistic Pelvic Care, the Arvigo Techniques of Maya Abdominal Therapy, Chi Nei Tsang visceral abdominal massage, and Cranial Sacral Therapy. By integrating these modalities, Dr. Wilkinson provides personalized and effective treatments tailored to each patient's unique needs, ensuring comprehensive wellness and healing.


Oliver Grundman Headshot

Oliver Grundman, PhD

"What is the Mi(gh)ter Hype of Kratom? Pharmacology, Potential Benefits and Harms of Mitragyna speciosa"

Kratom, a tree native to Southeast Asia also known by its Latin name Mitragyna speciosa, has gained substantial public interest in the US as a botanical product. Its alkaloids act on a number of receptor systems, including opioid, adrenergic, and serotonergic receptors leading to a complex pharmacology. The traditional use in Southeast Asia has not been reported to result in a use disorder although kratom extracts and concentrates sold in the US may lead to tolerance and dependence with frequent and high-dose consumption. This presentation focuses on the pharmacology, reported self-treatment of disorders, and detrimental or toxic effects of kratom.

Bio: Oliver Grundmann is a clinical professor at the College of Pharmacy and holds a courtesy appointment with the College of Nursing, University of Florida. He received his BPharm from the University of Münster, Germany before receiving his PhD in Pharmaceutical Sciences from the University of Florida. His research focuses on natural products and complementary and alternative medicines. He serves as section editor of the journal Current Addiction Reports, is the incoming president-elect of the American College of Clinical Pharmacology, and is working with various academic collaborators on the use and clinical impact of dietary supplements with a particular emphasis on kratom.


Georgina Cullen-Kerney

Georgina Cullen-Kerney, ND, MAc

"Magic Mushrooms: Including the Efficacy & Safety of Oregon Psilocybin Services"

More to come...






Leanna Standish Headshot

Leanna Standish, NMD

"Bringing Ayahuasca to North America: Technical and Ethical Challenges"

More to come...

Erica Zelfand Headshot

Erica Zelfand, ND

"Microdosing Psilocybin & LSD: What We Know So Far"

Dr. Erica Zelfand takes a deep-dive into the latest research on microdosing to summarize what we know - and what we don’t - about the effects of taking sub-perceptual doses of LSD and psilocybin. Featuring real cases from her practice, Dr. Zelfand explains various dosage protocols, reviews the literature available, and summarizes general trends. The proposed mechanisms of action of microdosing are explained, along with safety considerations and drug-drug interactions.

Bio: Dr. Erica Zelfand is the CEO of Right to Heal, a nonprofit organization dedicated to educating and empowering people around psychedelic healing and other life-saving techniques that conventional medicine has ignored.

Dr. Zelfand’s training and skill set span the spectrum of both conventional and natural approaches. She treats people of all ages and stages of life, from newborns to those approaching the end of life. Areas of focus within her family practice include: autoimmunity, endocrinology, and integrative mental health. She is deeply committed to patient-centered, root-cause-oriented, nature-honoring approaches to healing.

Dr. Zelfand is also a facilitator of therapeutic psycho-spiritual experiences, and regularly lectures on psychedelic science at medical institutions worldwide. She also trains practitioners in person and online, and is listed in the Portland Business Journal as a psilocybin trailblazer.

Dr. Zelfand loves sharing her knowledge, her reverence for nature, and her zesty sense of humor with her colleagues, her patients and clients, and audiences of all sizes worldwide. She is also a fan of dark chocolate and group hugs. To learn more and connect, please visit


Candace Lewis Headshot

Candace Lewis, PhD

"38 Million Moments Shaping Your Epigenome: Exploring Psychedelic Healing"

Dr. Lewis grew up in rural Alaska where she was exposed to high rates of poverty, mental illness, violence, and addictions. These personal experiences drove her commitment to revolutionize mental health understanding, treatment, and policy change. To this end, she earned a Masters in Counseling, a PhD in Behavioral Neuroscience, studied genomic science at a leading institution, and studied psychedelic science at the University of Zurich. Currently, Dr. Lewis lead the BEAR Lab (Brain, Epigenetics, & Altered states Research) at Arizona State University. Her lab’s research focuses on 1) the impact of early life social experiences on epigenetic regulation of gene systems involved in mental health; 2) the relationships between peripheral epigenetics and brain structure, function, microbiome composition, and behavior; and 3) the potential of psychedelic-assisted therapy to reduce symptoms through psychological healing and epigenetic alterations. Through her research, she aims to acknowledge the harm caused by psychology and genetic sciences on minority groups, increase diversity in training and study cohorts, and change policy to improve mental health for all. When not working, Dr. Lewis enjoys family time with her three sons and wife, going to music festivals, hiking, running, reading, creative writing, and talking about all things spirituality, social justice, and science.


Austin Perlmutter HeadshotAustin Perlmutter, MD

"Psychedelics: Effectors of Neuroinflammatory Programming"

Brain-related diseases and disorders are among the most debilitating and deadly conditions on Earth. Yet by and large, conventional pharmaceutical management targeting individual neurotransmitters or proteins (e.g., serotonin in depression, amyloid beta in Alzheimer’s dementia) have fallen short of expectations. This has led to a growing interest in identifying additional disease-related pathways and interventions to help ameliorate physical, emotional and economic costs. In this conversation, neuroinflammation and psychedelics have each emerged as areas of intense academic research and potential sources of solutions. Neuroinflammation is now believed to underlie or significantly contribute to mental health, cognitive, neurodevelopmental and behavior disorders and diseases. Psychedelics represent promising compounds for ameliorating a host of brain-related conditions. In this presentation, we’ll explore the known overlap between the two domains while looking ahead towards the promise this may hold for the future of brain health.

Bio: Dr. Austin Perlmutter is a board-certified internal medicine physician, New York Times bestselling author, published researcher and international educator. His mission is to help people improve their health by targeting the biological basis of “stuckness” in our brains and bodies. His writing, presentations, podcasts, and online educational programs explore how environmental factors influence our cognitive and mental state and have reached millions. Dr. Perlmutter has been featured on PBS, Rolling Stone, MedPage today, Newsweek, Medical News Today, NPR and a wide range of other media outlets. He is a co-producer of the Alzheimer’s, the Science of Prevention series, and host of the Better Brain Blueprint series. Dr. Perlmutter currently serves as the managing director at Big Bold Health, a food-as-medicine company focused on helping people rejuvenate health through better immune function, where he is running a first-of-its kind study exploring the effects of plant nutrients on human aging through epigenetics.


Alicia Bigelow Headshot

Alicia Bigelow, ND

"Clinical Ketamine Use: Considerations in Special Populations"

In this lecture, Dr Bigelow will delve into the therapeutic application of IV ketamine in populations where its use requires special consideration, such as in women with postpartum depression, and individuals with alcohol use disorder.  Attendees will gain insights into the unique factors to consider when treating members of these populations and how IV ketamine therapy can be tailored to address their specific needs. Through a blend of clinical case studies, empirical evidence, and practical considerations, this session will provide a comprehensive overview of IV ketamine's efficacy, safety, and role in optimizing mental health outcomes across several special populations.

Speaker Bio: In 2004, Dr. Bigelow earned her Doctor of Naturopathic Medicine degree from the National University of Natural Medicine (NUNM). Following her academic training, she completed a two-year residency at NUNM and continued on as a clinical and academic faculty member for 15 years with a specific focus on IV therapy and Environmental Medicine. During that time, she worked with patients with complex chronic disease and cancer. Her experiences working with patients facing serious illnesses underscored the importance of an integrative approach to health, incorporating mental, emotional, spiritual, and physical well-being. This prompted her to deepen her training in mental health from a holistic perspective. Subsequently, she sought specialized training at Polaris Insight Center for Ketamine-Assisted Therapy, began a mentorship at Cascade Psychedelic Medicine and pursued training in psilocybin facilitation with InnerTrek and Right to Heal.

She offers consultations and facilitates psilocybin retreats in Mexico through the non-profit organization, Right to Heal, and is an Oregon-licensed psilocybin facilitator. She also provides IV Ketamine with accompanying sound baths to patients with depression and other psychiatric ailments at Cascade Psychedelic Medicine in Portland, OR.

Required Category:

Rates Price
Healthcare Provider Rate: 2024 Psychedelic Odyssey $325.00
Alumni Rate: 2024 Psychedelic Odyssey $300.00
Student Rate: 2024 Psychedelic Odyssey $75.00